Center For Scientific Review; Notice of Closed Meetings
Published Date: 11/26/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 11-12, 2025, to review important grant applications. This meeting was delayed due to a government shutdown but is now urgent to keep vital health research funding on track. Scientists and researchers waiting on NIH grants are affected, with no cost to attend and no public access to protect privacy and secrets.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed Virtual NIH Grant Review
The NIH Center for Scientific Review will hold a closed virtual meeting on December 11-12, 2025 (9:00 a.m. to 6:00 p.m.) to review and evaluate grant applications. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6), is virtual, and the notice states registration is not required to attend.
Shutdown-Delay and Urgent Rescheduling
The meeting was canceled earlier because of a 43-day government shutdown and is being held urgently less than 15 days after the notice so evaluations can be submitted to national advisory councils for timely funding recommendations. The notice says this urgency is to keep disbursement of NIH funds on track for biomedical research addressing major public health priorities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2025-21287 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 9, 2026, to review important grant applications about respiratory health. These meetings are private to protect secret ideas and personal info. Scientists and researchers applying for grants should note this schedule, but no new costs or changes affect them.
Next: 2025-21289 — Steel Concrete Reinforcing Bar From the Republic of Türkiye: Notice of Court Decision Not in Harmony With the Results of Countervailing Duty Administrative Review; Notice of Amended Final Results
The U.S. Court of International Trade changed the rules on how much extra tax (called countervailing duty) two Turkish steel companies, Kaptan and Icdas, have to pay on their steel rebar sold in the U.S. This means the government is updating the tax rates starting October 16, 2025, which could affect prices and payments for these companies. If you’re involved in importing or selling this steel, keep an eye on these new numbers!